Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer-Reference-Cited by-同舟云学术

Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer

Published:2017-09-25 Issue:1 Volume:67 Page:89-100
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Fucikova Jitka,Podrazil Michal,Jarolim Ladislav,Bilkova Pavla,Hensler Michal,Becht Etienne,Gasova Zdenka,Klouckova Jana,Kayserova Jana,Horvath Rudolf,Fialova Anna,Vavrova Katerina,Sochorova Klara,Rozkova Daniela,Spisek Radek,Bartunkova Jirina

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/article/10.1007/s00262-017-2068-x/fulltext.html

Reference28 articles.

1. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9–29

2. Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, Bray F (2012) International variation in prostate cancer incidence and mortality rates. Eur Urol 61(6):1079–1092

3. Denmeade SR, Isaacs JT (2002) A history of prostate cancer treatment. Nat Rev Cancer 2(5):389–396

4. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281(17):1591–1597

5. Walsh PC, DeWeese TL, Eisenberger MA (2007) Clinical practice. Localized prostate cancer. N Engl J Med 357(26):2696–2705

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current state of knowledge and challenges for harnessing the power of dendritic cells in cancer immunotherapy;Pathology - Research and Practice;2024-01

2. Nanosensor Chemical Cytometry: Advances and Opportunities in Cellular Therapy and Precision Medicine;ACS Measurement Science Au;2023-11-01

3. Theranostic chimeric antigen receptor (CAR)-T cells: Insight into recent trends and challenges in solid tumors;Life Sciences;2023-09

4. Potential of Personalized Dendritic Cell-Based Immunohybridoma Vaccines to Treat Prostate Cancer;Life;2023-07-01

5. Advances in Immunotherapy and Vaccine for Prostate Cancer;annals of urologic oncology;2023-05-27